Last Updated: 09 Nov 2024
Executive Summary
Kenvue Inc. (KVUE) is a leading consumer health company with a global presence. The company's stock has performed well in recent years, and analysts are generally bullish on its prospects. The latest stock price of $23.68 is near the 52-week high of $23.72.
Company Overview
Kenvue Inc. is a consumer health company that develops, manufactures, and markets a wide range of products, including over-the-counter medications, personal care products, and nutritional supplements. The company's products are sold in over 100 countries around the world. Kenvue Inc. is headquartered in Skillman, New Jersey.
Fundamental Analysis
Kenvue Inc.'s financial performance has been strong in recent years. The company's revenue has grown steadily, and its profitability has improved. In 2023, the company reported revenue of $15.46 billion and net income of $1.05 billion. Kenvue Inc.'s financial ratios are also healthy. The company's gross profit margin is 54.0%, and its operating margin is 20.2%. The company's return on assets is 6.97%, and its return on equity is 10.5%.
Technical Analysis
Kenvue Inc.'s stock price has been trending higher in recent months. The stock is currently trading above its 50-day and 200-day moving averages. The stock's relative strength index (RSI) is 65.0, which indicates that the stock is overbought. However, the stock's moving average convergence divergence (MACD) is positive, which indicates that the stock is still in a bullish trend.
Short Term Outlook
In the short term, Kenvue Inc.'s stock price is likely to continue to trade higher. The stock's technical indicators are bullish, and the company's financial performance is strong. However, the stock's RSI is overbought, which could indicate that the stock is due for a pullback.
Long Term Outlook
In the long term, Kenvue Inc.'s stock price is likely to continue to rise. The company's products are in high demand, and the company's financial performance is strong. The company is also well-positioned to benefit from the growing global demand for consumer health products.
Analyst Recommendations
Analysts are generally bullish on Kenvue Inc.'s stock. The consensus price target for the stock is $23.99, which represents a potential upside of 1.3% from the current price. Of the 16 analysts who cover the stock, 1 has a strong buy rating, 6 have a buy rating, 8 have a hold rating, and 1 has a sell rating.
